Skip to main content
. 2023 Jun;29(6):10.18553/jmcp.2023.29.6.692. doi: 10.18553/jmcp.2023.29.6.692

TABLE 4.

Votes on Other Contextual Considerations (Fezolinetant vs No Pharmacologic Treatment [Neither Prescription nor Nonprescription])

Contextual consideration Very low priority Low priority Average priority High priority Very high priority
Patients’ ability to achieve major life goals related to education, work, or family life 0 1 7 4 0
Caregivers’ quality of life and/or ability to achieve major life goals related to education, work, or family life 0 0 11 1 0
Society’s goal of reducing health inequities 0 1 6 5 0